Furthermore, using functional assays we have demonstrated that these miRNA inhibited their target genes including RARA, IFN type I genes, FRA2 and TAB1, respectively in RA and SSc monocytes and SSc fibroblasts (7–10). The gene discussed is TAB1; the disease is systemic sclerosis.